Trial Profile
Does repeated daily testing improve measurement sensitivity to the cognitive effects of donepezil in mild to moderate AD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2011
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 05 Aug 2011 New trial record